Citation Impact
Citing Papers
AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging
2019
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
2021
Macrophages in immunoregulation and therapeutics
2023 Standout
Time-resolved single-cell analysis of Brca1 associated mammary tumourigenesis reveals aberrant differentiation of luminal progenitors
2021
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression
2021 StandoutNobel
Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
2020
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
2019
Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
2021
Tumor-Associated Neutrophils in Cancer: Going Pro
2019
Works of Priscilla S. Redd being referenced
Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis
2018
An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion
2018
The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells
2016
Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes
2019
Asah2 Represses the p53–Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis
2021